Astrocyte Pharmaceuticals Inc.
Astrocyte Pharmaceuticals develops treatments intended to protect brain tissue after concussion, traumatic brain injury and stroke by targeting astrocytes.
$9.5MSeries B
LeadDC
DeepWork Capital
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Jul 20, 2026
DeepWork Capital is a Florida-based investment manager whose official portfolio includes Biota, FirmPilot and Astrocyte. Rapta also names the firm in its announcement.
Recorded funding activity
Astrocyte develops treatments intended to protect brain tissue after injury. Rapta uses cameras and sensors to guide manufacturing and catch errors, while Biota develops faster monitoring for PFAS. These companies address distinct clinical, industrial and environmental problems.
Sources
- Rounds participated in
- 3
- Confirmed lead rounds
- 1 1 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $20.5M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionRapta
Manufacturing intelligence software that uses cameras and sensors to guide workstations and catch assembly errors as they happen.
$8MFunding
ParticipantBiota
Environmental diagnostics company developing faster technologies for PFAS monitoring and analysis.
$3MSeed
Role not disclosed